Swiss National Bank’s Olema Pharmaceuticals OLMA Stock Holding History

Swiss National Bank’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.31M	Buy	105,000 +30,400	+41%	+$407K	﹤0.01%	2127
2026 Q1	$1.11M	Buy	+74,600	New	+$1.66M	﹤0.01%	2115
2025 Q1	–	Sell	-66,000	Closed	-$385K	–	2438
2024 Q4	$385K	Hold	66,000	–	–	﹤0.01%	2422
2024 Q3	$788K	Hold	66,000	–	–	﹤0.01%	2316
2024 Q2	$714K	Sell	66,000 -4,300	-6%	-$46.6K	﹤0.01%	2314
2024 Q1	$796K	Buy	70,300 +5,700	+9%	+$73.5K	﹤0.01%	2323
2023 Q4	$906K	Buy	+64,600	New	+$868K	﹤0.01%	2295
2022 Q2	–	Sell	-21,800	Closed	-$93K	–	2774
2022 Q1	$93K	Hold	21,800	–	–	﹤0.01%	2689
2021 Q4	$204K	Buy	+21,800	New	+$452K	﹤0.01%	2717

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Swiss National Bank's OLMA Position: Q2 2026 in Review

Swiss National Bank increased its Olema Pharmaceuticals (OLMA) stake by 41% in Q2 2026, buying an estimated $407K and bringing the position to 105,000 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2127.

Swiss National Bank first reported a position in OLMA in Q4 2021 and has held it in 9 quarters since. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Swiss National Bank held 105,000 shares of Olema Pharmaceuticals worth $1.31M as of Q2 2026.
Swiss National Bank bought 30,400 Olema Pharmaceuticals shares in Q2 2026, an estimated $407K.
Olema Pharmaceuticals made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #2127 holding.
Swiss National Bank first reported a position in Olema Pharmaceuticals in Q4 2021 and has held it in 9 quarters since.
185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.